Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1994 4
1996 2
1997 2
1998 3
1999 3
2000 7
2001 12
2002 5
2003 3
2004 8
2005 6
2006 6
2007 7
2008 9
2009 10
2010 10
2011 17
2012 6
2013 7
2014 11
2015 12
2016 16
2017 17
2018 18
2019 11
2020 15
2021 24
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Results by year
Filters applied: . Clear all
Page 1
Comparative review of imipenem/cilastatin versus meropenem.
Salmon-Rousseau A, Martins C, Blot M, Buisson M, Mahy S, Chavanet P, Piroth L. Salmon-Rousseau A, et al. Among authors: piroth l. Med Mal Infect. 2020 Jun;50(4):316-322. doi: 10.1016/j.medmal.2020.01.001. Epub 2020 Feb 5. Med Mal Infect. 2020. PMID: 32035719 Review.
The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.
Tubiana S, Duval X, Alla F, Selton-Suty C, Tattevin P, Delahaye F, Piroth L, Chirouze C, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Iung B, Le Moing V; VIRSTA/AEPEI Study Group. Tubiana S, et al. Among authors: piroth l. J Infect. 2016 May;72(5):544-53. doi: 10.1016/j.jinf.2016.02.003. Epub 2016 Feb 22. J Infect. 2016. PMID: 26916042 Free article.
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy study group. Ader F, et al. Among authors: piroth l. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26. Clin Microbiol Infect. 2021. PMID: 34048876 Free PMC article. Clinical Trial.
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C; French COVID cohort study and investigators groups. Ghosn J, et al. Among authors: piroth l. Clin Microbiol Infect. 2021 Jul;27(7):1041.e1-1041.e4. doi: 10.1016/j.cmi.2021.03.012. Epub 2021 May 10. Clin Microbiol Infect. 2021. PMID: 34125067 Free PMC article.
Vertebral Hydatidosis.
Jacquier M, Piroth L. Jacquier M, et al. Among authors: piroth l. N Engl J Med. 2018 Jul 12;379(2):e5. doi: 10.1056/NEJMicm1714206. N Engl J Med. 2018. PMID: 29996078 Free article. No abstract available.
Isolated Anti-HBc: Significance and Management.
Moretto F, Catherine FX, Esteve C, Blot M, Piroth L. Moretto F, et al. Among authors: piroth l. J Clin Med. 2020 Jan 11;9(1):202. doi: 10.3390/jcm9010202. J Clin Med. 2020. PMID: 31940817 Free PMC article. Review.
[Influenza infection: An update for clinicians].
Blot M, Chavanet P, Piroth L. Blot M, et al. Among authors: piroth l. Rev Med Interne. 2019 Mar;40(3):158-165. doi: 10.1016/j.revmed.2018.12.010. Epub 2019 Jan 11. Rev Med Interne. 2019. PMID: 30638964 Review. French.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D; COVERAGE study group. Duvignaud A, et al. Among authors: piroth l. Trials. 2020 Oct 13;21(1):846. doi: 10.1186/s13063-020-04619-1. Trials. 2020. PMID: 33050924 Free PMC article. Clinical Trial.
Proposal for shorter antibiotic therapies.
Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, Lesprit P, Maulin L, Péan Y, Peju E, Piroth L, Stahl JP, Strady C, Varon E, Vuotto F, Gauzit R; Recommendation Group of the SPILF. Wintenberger C, et al. Among authors: piroth l. Med Mal Infect. 2017 Mar;47(2):92-141. doi: 10.1016/j.medmal.2017.01.007. Epub 2017 Mar 6. Med Mal Infect. 2017. PMID: 28279491 Review.
252 results